Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT06614205
Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma
Sponsor: Central Hospital, Nancy, France
View on ClinicalTrials.gov
Summary
The hypothesis for this study is that there is a dose-response relationship in patients treated with 177Lu-DOTATATE for meningiomas.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
11
Start Date
2024-11-01
Completion Date
2025-02-25
Last Updated
2026-06-25
Healthy Volunteers
Not specified
Conditions
Interventions
DIAGNOSTIC_TEST
tumoral dosimetry by scintigraphy
The tumoral dosimetry has been done on patient after treatment by 177Lu-DOTATATE Theses patients performed a scintigraphy exam at D1, D4 and D7 after the treatment
Locations (2)
CHRU de NANCY
Vandœuvre-lès-Nancy, France
Nuclear medicine Department CHRU de NANCY
Vandœuvre-lès-Nancy, France